Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 103

1.

Relationships between Atherosclerosis and Plasma Antioxidant Micronutrients or Red Blood Cell Polyunsaturated Fatty Acids in People Living with HIV.

Schwenger KJP, Arendt BM, Smieja M, Ma DWL, Smaill F, Allard JP.

Nutrients. 2019 Jun 7;11(6). pii: E1292. doi: 10.3390/nu11061292.

2.

The Efficacy of the Quadrivalent Human Papillomavirus Vaccine in Girls and Women Living With Human Immunodeficiency Virus.

McClymont E, Lee M, Raboud J, Coutlée F, Walmsley S, Lipsky N, Loutfy M, Trottier S, Smaill F, Klein MB, Harris M, Cohen J, Yudin MH, Wobeser W, Money D; CTN 236 HPV in HIV Study Team .

Clin Infect Dis. 2019 Feb 15;68(5):788-794. doi: 10.1093/cid/ciy575.

PMID:
29985988
3.

New Tuberculosis Vaccine Strategies: Taking Aim at Un-Natural Immunity.

Jeyanathan M, Yao Y, Afkhami S, Smaill F, Xing Z.

Trends Immunol. 2018 May;39(5):419-433. doi: 10.1016/j.it.2018.01.006. Epub 2018 Feb 9. Review.

PMID:
29429859
4.

Pathways From HIV-Related Stigma to Antiretroviral Therapy Measures in the HIV Care Cascade for Women Living With HIV in Canada.

Logie CH, Lacombe-Duncan A, Wang Y, Kaida A, Conway T, Webster K, de Pokomandy A, Loutfy MR, Anema A, Becker D, Brotto L, Carter A, Cardinal C, Colley G, Ding E, Duddy J, Gataric N, Hogg RS, Hosward T, Jabbari S, Jones E, Kestler M, Langlois A, Lima V, Lloyd-Smith E, Medjuck M, Miller C, Money D, Nicholson V, Ogilvie G, Patterson S, Pick N, Roth E, Salters K, Sanchez M, Sas J, Sereda P, Summers M, Tom C, Wang L, Webster K, Zhang W, Abdul-Noor R, Angel J, Barry F, Bauer G, Beaver K, Benoit A, Bertozzi B, Borton S, Bourque T, Brophy J, Burchell A, Carlson A, Cioppa L, Cohen J, Conway T, Cooper C, Cotnam J, Cousineau J, Fraleigh A, Gagnier B, Gasingirwa C, Greene S, Hart T, Islam S, Kaushic C, Kennedy L, Kerr D, Kiboyogo M, Kwaramba G, Leonard L, Lewis J, Logie C, Margolese S, Muchenje M, Ndungʼu M, OʼBrien K, Ouellette C, Powis J, Quan C, Raboud J, Rachlis A, Ralph E, Rourke S, Rueda S, Sandre R, Smaill F, Smith S, Tigere T, Tharao W, Walmsley S, Wobeser W, Yee J, Yudin M, Baril JG, Burke NB, Clément P, Dayle J, Dubuc D, Fernet M, Groleau D, Hot A, Klein M, Martin C, Massie L, Ménard B, OʼBrien N, Otis J, Peltier D, Pierre A, Proulx-Boucher K, Rouleau D, Savoie É, Tremblay C, Trottier B, Trottier S, Tsoukas C, Gahagan J, Hankins C, Masching R, Ogunnaike-Cooke S.

J Acquir Immune Defic Syndr. 2018 Feb 1;77(2):144-153. doi: 10.1097/QAI.0000000000001589.

5.

Vitamin D and progression of carotid intima-media thickness in HIV-positive Canadians.

Huff H, Merchant AT, Lonn E, Pullenayegum E, Smaill F, Smieja M.

HIV Med. 2018 Feb;19(2):143-151. doi: 10.1111/hiv.12563. Epub 2017 Nov 6.

PMID:
29110385
6.

Exploring the Factors Considered by People Living with HIV and Their Partners during Preconception.

Kennedy VL, Collins M, Yudin MH, Serghides L, Walmsley S, Angel JB, Ongoiba F, Powis J, Smaill F, Tharao W, Rachlis A, Silverman M, Sandre R, Regier DA, Loutfy M.

J Int Assoc Provid AIDS Care. 2017 May/Jun;16(3):239-246. doi: 10.1177/2325957416682089. Epub 2016 Dec 19.

PMID:
28485707
7.

Induction of an Immune-Protective T-Cell Repertoire With Diverse Genetic Coverage by a Novel Viral-Vectored Tuberculosis Vaccine in Humans.

Jeyanathan M, Damjanovic D, Yao Y, Bramson J, Smaill F, Xing Z.

J Infect Dis. 2016 Dec 15;214(12):1996-2005. Epub 2016 Oct 4.

8.

HIV viral suppression results in higher antibody responses in HIV-positive women vaccinated with the quadrivalent human papillomavirus vaccine.

Money DM, Moses E, Blitz S, Vandriel SM, Lipsky N, Walmsley SL, Loutfy M, Trottier S, Smaill F, Yudin MH, Klein M, Harris M, Cohen J, Wobeser W, Bitnun A, Lapointe N, Samson L, Brophy J, Karatzios C, Ogilvie G, Coutlée F, Raboud J; HPV in HIV Study Group.

Vaccine. 2016 Sep 14;34(40):4799-806. doi: 10.1016/j.vaccine.2016.08.016. Epub 2016 Aug 17.

PMID:
27544584
9.

In HIV-1, immediate vs deferred antiretroviral therapy and isoniazid vs no isoniazid reduced severe illness at 30 mo.

Smaill F.

Ann Intern Med. 2015 Dec 15;163(12):JC5. doi: 10.7326/ACPJC-2015-163-12-005. No abstract available.

PMID:
26666807
10.

In early HIV infection, immediate vs deferred antiretroviral therapy reduced serious illnesses at 3 years.

Smaill F.

Ann Intern Med. 2015 Dec 15;163(12):JC4. doi: 10.7326/ACPJC-2015-163-12-004. No abstract available.

PMID:
26666806
11.

Antibiotics for asymptomatic bacteriuria in pregnancy.

Smaill FM, Vazquez JC.

Cochrane Database Syst Rev. 2015 Aug 7;(8):CD000490. doi: 10.1002/14651858.CD000490.pub3. Review.

PMID:
26252501
12.

The effects of HIV-1 subtype and ethnicity on the rate of CD4 cell count decline in patients naive to antiretroviral therapy: a Canadian-European collaborative retrospective cohort study.

Klein MB, Young J, Dunn D, Ledergerber B, Sabin C, Cozzi-Lepri A, Dabis F, Harrigan R, Tan DH, Walmsley S, Gill J, Cooper C, Scherrer AU, Mocroft A, Hogg RS, Smaill F; Canadian−European Clade Collaboration.

CMAJ Open. 2014 Oct 1;2(4):E318-29. doi: 10.9778/cmajo.20140017. eCollection 2014 Oct.

13.

Antibiotic prophylaxis versus no prophylaxis for preventing infection after cesarean section.

Smaill FM, Grivell RM.

Cochrane Database Syst Rev. 2014 Oct 28;(10):CD007482. doi: 10.1002/14651858.CD007482.pub3. Review.

PMID:
25350672
14.

New approaches to TB vaccination.

Xing Z, Jeyanathan M, Smaill F.

Chest. 2014 Sep;146(3):804-812. doi: 10.1378/chest.14-0439.

PMID:
25180725
15.

Human type 5 adenovirus-based tuberculosis vaccine: is the respiratory route of delivery the future?

Smaill F, Xing Z.

Expert Rev Vaccines. 2014 Aug;13(8):927-30. doi: 10.1586/14760584.2014.929947. Epub 2014 Jun 17.

PMID:
24935214
16.

The importance of motherhood in HIV-positive women of reproductive age in Ontario, Canada.

Kennedy VL, Serghides L, Raboud JM, Su D, Blitz S, Hart TA, Walmsley SL, Angel JB, Smaill FM, Ralph ED, Tharao WE, Loutfy MR; Ontario HIV Fertility Research Team.

AIDS Care. 2014;26(6):777-84. doi: 10.1080/09540121.2013.855295. Epub 2013 Nov 9.

PMID:
24206065
17.

A human type 5 adenovirus-based tuberculosis vaccine induces robust T cell responses in humans despite preexisting anti-adenovirus immunity.

Smaill F, Jeyanathan M, Smieja M, Medina MF, Thanthrige-Don N, Zganiacz A, Yin C, Heriazon A, Damjanovic D, Puri L, Hamid J, Xie F, Foley R, Bramson J, Gauldie J, Xing Z.

Sci Transl Med. 2013 Oct 2;5(205):205ra134. doi: 10.1126/scitranslmed.3006843.

18.

Antivirals for influenza: a summary of a systematic review and meta-analysis of observational studies.

Santesso N, Hsu J, Mustafa R, Brozek J, Chen YL, Hopkins JP, Cheung A, Hovhannisyan G, Ivanova L, Flottorp SA, Saeterdal I, Wong AD, Tian J, Uyeki TM, Akl EA, Alonso-Coello P, Smaill F, Schünemann HJ.

Influenza Other Respir Viruses. 2013 Sep;7 Suppl 2:76-81. doi: 10.1111/irv.12085. Review.

19.

Self-Reported Preconception Care of HIV-Positive Women of Reproductive Potential: A Retrospective Study.

Loutfy MR, Blitz S, Zhang Y, Hart TA, Walmsley SL, Smaill FM, Rachlis AR, Yudin MH, Angel JB, Ralph ED, Tharao W, Raboud JM; Ontario HIV Fertility Research Team.

J Int Assoc Provid AIDS Care. 2014 Sep-Oct;13(5):424-33. doi: 10.1177/2325957413494238. Epub 2013 Aug 5.

PMID:
23918921
20.

Factors affecting antiretroviral pharmacokinetics in HIV-infected women with virologic suppression on combination antiretroviral therapy: a cross-sectional study.

Loutfy MR, Walmsley SL, Klein MB, Raboud J, Tseng AL, Blitz SL, Pick N, Conway B, Angel JB, Rachlis AR, Gough K, Cohen J, Haase D, Burdge D, Smaill FM, de Pokomandy A, Loemba H, Trottier S, la Porte CJ.

BMC Infect Dis. 2013 Jun 3;13:256. doi: 10.1186/1471-2334-13-256.

21.

Evaluation of HIV and highly active antiretroviral therapy on the natural history of human papillomavirus infection and cervical cytopathologic findings in HIV-positive and high-risk HIV-negative women.

Blitz S, Baxter J, Raboud J, Walmsley S, Rachlis A, Smaill F, Ferenczy A, Coutlée F, Hankins C, Money D; Canadian Women's HIV Study Group.

J Infect Dis. 2013 Aug 1;208(3):454-62. doi: 10.1093/infdis/jit181. Epub 2013 Apr 26.

PMID:
23624362
22.

Herpes simplex virus type 2 coinfection does not accelerate CD4 count decline in untreated HIV infection.

Tan DH, Raboud JM, Kaul R, Brunetta J, Kaushic C, Kovacs C, Lee E, Luetkehoelter J, Rachlis A, Smaill F, Smieja M, Walmsley SL.

Clin Infect Dis. 2013 Aug;57(3):448-57. doi: 10.1093/cid/cit208. Epub 2013 Apr 9.

PMID:
23572481
23.

Antivirals for treatment of influenza: a systematic review and meta-analysis of observational studies.

Hsu J, Santesso N, Mustafa R, Brozek J, Chen YL, Hopkins JP, Cheung A, Hovhannisyan G, Ivanova L, Flottorp SA, Saeterdal I, Wong AD, Tian J, Uyeki TM, Akl EA, Alonso-Coello P, Smaill F, Schünemann HJ.

Ann Intern Med. 2012 Apr 3;156(7):512-24. doi: 10.7326/0003-4819-156-7-201204030-00411. Epub 2012 Feb 27. Review.

PMID:
22371849
24.

WITHDRAWN: Antibiotic prophylaxis regimens and drugs for cesarean section.

Hopkins L, Smaill FM.

Cochrane Database Syst Rev. 2012 Jan 18;1:CD001136. doi: 10.1002/14651858.CD001136.pub2. Review.

PMID:
22258944
25.

High prevalence of unintended pregnancies in HIV-positive women of reproductive age in Ontario, Canada: a retrospective study.

Loutfy M, Raboud J, Wong J, Yudin M, Diong C, Blitz S, Margolese S, Hart T, Ogilvie G, Masinde K, Tharao W, Linklater G, Salam K, Ongoiba F, Angel J, Smaill F, Rachlis A, Ralph E, Walmsley S; Ontario HIV Fertility Research Team.

HIV Med. 2012 Feb;13(2):107-17. doi: 10.1111/j.1468-1293.2011.00946.x. Epub 2011 Nov 21.

26.

Safety and tolerability of varenicline tartrate (Champix(®)/Chantix(®)) for smoking cessation in HIV-infected subjects: a pilot open-label study.

Cui Q, Robinson L, Elston D, Smaill F, Cohen J, Quan C, McFarland N, Thabane L, McIvor A, Zeidler J, Smieja M.

AIDS Patient Care STDS. 2012 Jan;26(1):12-9. doi: 10.1089/apc.2011.0199. Epub 2011 Oct 18.

27.

A randomized controlled trial of HIV therapeutic vaccination using ALVAC with or without Remune.

Angel JB, Routy JP, Tremblay C, Ayers D, Woods R, Singer J, Bernard N, Kovacs C, Smaill F, Gurunathan S, Sekaly RP.

AIDS. 2011 Mar 27;25(6):731-9. doi: 10.1097/QAD.0b013e328344cea5.

PMID:
21330911
28.

A comparison of the MOS-HIV and SF-12v2 for measuring health-related quality of life of men and women living with HIV/AIDS.

Ion A, Cai W, Elston D, Pullenayegum E, Smaill F, Smieja M.

AIDS Res Ther. 2011 Jan 27;8(1):5. doi: 10.1186/1742-6405-8-5.

29.

Effect of smoking on lung function, respiratory symptoms and respiratory diseases amongst HIV-positive subjects: a cross-sectional study.

Cui Q, Carruthers S, McIvor A, Smaill F, Thabane L, Smieja M.

AIDS Res Ther. 2010 Mar 19;7:6. doi: 10.1186/1742-6405-7-6.

30.

Antibiotic prophylaxis versus no prophylaxis for preventing infection after cesarean section.

Smaill FM, Gyte GM.

Cochrane Database Syst Rev. 2010 Jan 20;(1):CD007482. doi: 10.1002/14651858.CD007482.pub2. Review. Update in: Cochrane Database Syst Rev. 2014;10:CD007482.

31.

WITHDRAWAN. Antibiotic prophylaxis for cesarean section.

Hofmeyr GJ, Smaill FM.

Cochrane Database Syst Rev. 2010 Jan 20;(1):CD000933. doi: 10.1002/14651858.CD000933.pub2. Review.

PMID:
20091509
32.

WITHDRAWN. Intrapartum antibiotics for Group B streptococcal colonisation.

Smaill FM.

Cochrane Database Syst Rev. 2010 Jan 20;(1):CD000115. doi: 10.1002/14651858.CD000115.pub2. Review.

PMID:
20091501
33.

Fertility desires and intentions of HIV-positive women of reproductive age in Ontario, Canada: a cross-sectional study.

Loutfy MR, Hart TA, Mohammed SS, Su D, Ralph ED, Walmsley SL, Soje LC, Muchenje M, Rachlis AR, Smaill FM, Angel JB, Raboud JM, Silverman MS, Tharao WE, Gough K, Yudin MH; Ontario HIV Fertility Research Team.

PLoS One. 2009 Dec 7;4(12):e7925. doi: 10.1371/journal.pone.0007925.

34.

Comparison of brachial and carotid artery ultrasound for assessing extent of subclinical atherosclerosis in HIV: a prospective cohort study.

Odueyungbo A, Smieja M, Thabane L, Smaill F, Gough K, Gill J, Anderson T, Elston D, Smith S, Beyene J, Lonn E.

AIDS Res Ther. 2009 Jun 11;6:11. doi: 10.1186/1742-6405-6-11.

35.

Antiviral activity and safety of aplaviroc, a CCR5 antagonist, in combination with lopinavir/ritonavir in HIV-infected, therapy-naïve patients: results of the EPIC study (CCR100136).

Yeni P, Lamarca A, Berger D, Cimoch P, Lazzarin A, Salvato P, Smaill FM, Teofilo E, Madison SJ, Nichols WG, Adkison KK, Bonny T, Millard J, McCarty D; EPIC (CCR100136) study team.

HIV Med. 2009 Feb;10(2):116-24. doi: 10.1111/j.1468-1293.2008.00660.x.

36.

A prospective study of body fat redistribution, lipid, and glucose parameters in HIV-infected patients initiating combination antiretroviral therapy.

Walmsley S, Cheung AM, Fantus G, Gough K, Smaill F, Azad, Diong C, Raboud J.

HIV Clin Trials. 2008 Sep-Oct;9(5):314-23. doi: 10.1310/hct0905-314.

PMID:
18977720
37.

Asymptomatic bacteriuria and symptomatic urinary tract infections in pregnancy.

Schnarr J, Smaill F.

Eur J Clin Invest. 2008 Oct;38 Suppl 2:50-7. doi: 10.1111/j.1365-2362.2008.02009.x. Review.

PMID:
18826482
38.

Canadian Consensus Recommendations for the Optimal Use of Enfuvirtide in HIV/AIDS Patients.

Rachlis A, Angel J, Harris M, Lalonde R, Smaill F, Tremblay C, Tsoukas C, Walmsley S.

Can J Infect Dis Med Microbiol. 2006 May;17(3):155-63.

39.

Identification of residues in the receptor-binding domain (RBD) of the spike protein of human coronavirus NL63 that are critical for the RBD-ACE2 receptor interaction.

Lin HX, Feng Y, Wong G, Wang L, Li B, Zhao X, Li Y, Smaill F, Zhang C.

J Gen Virol. 2008 Apr;89(Pt 4):1015-24. doi: 10.1099/vir.0.83331-0.

PMID:
18343844
40.

Outbreaks of infection caused by community-acquired methicillin-resistant Staphylococcus aureus in a Canadian correctional facility.

Main CL, Jayaratne P, Haley A, Rutherford C, Smaill F, Fisman DN.

Can J Infect Dis Med Microbiol. 2005 Nov;16(6):343-8.

41.

Identification badges: a potential fomite?

Ota K, Profiti R, Smaill F, Matlow AG, Smieja M.

Can J Infect Control. 2007 Fall;22(3):162, 165-6.

PMID:
18044386
42.

Pathogen inactivation: making decisions about new technologies. Report of a consensus conference.

Klein HG, Anderson D, Bernardi MJ, Cable R, Carey W, Hoch JS, Robitaille N, Sivilotti ML, Smaill F.

Transfusion. 2007 Dec;47(12):2338-47. No abstract available.

PMID:
18036075
43.

Randomized controlled trial of once-daily tenofovir, lamivudine, and lopinavir/ritonavir versus remaining on the same regimen in virologically suppressed HIV-infected patients on their first PI-containing HAART regimen.

Loutfy MR, Ackad N, Antoniou T, Baril JG, Conway B, de Wet J, Trottier B, Kovacs CM, Thompson W, Martel AY, Trottier S, Rouleau D, Shafran SD, Rachlis A, Fraser C, Smaill F, Walmsley SL, Tseng AL, Sampalis JS.

HIV Clin Trials. 2007 Sep-Oct;8(5):259-68.

PMID:
17956827
44.

A large prospective study assessing injection site reactions, quality of life and preference in patients using the Biojector vs standard needles for enfuvirtide administration.

Loutfy MR, Harris M, Raboud JM, Antoniou T, Kovacs C, Shen S, Dufresne S, Smaill F, Rouleau D, Rachlis A, Gough K, Lalonde R, Tsoukas C, Trottier B, Walmsley SL, Montaner JS.

HIV Med. 2007 Oct;8(7):427-32.

45.

Pathogen inactivation: making decisions about new technologies - preliminary report of a consensus conference.

Klein HG, Anderson D, Bernardi MJ, Cable R, Carey W, Hoch JS, Robitaille N, Sivilotti ML, Smaill F.

Vox Sang. 2007 Aug;93(2):179-82. No abstract available.

PMID:
17683364
46.

Occult hepatitis B virus infection in the setting of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection: clinically relevant or a diagnostic problem?

Rodríguez-Torres M, Gonzalez-Garcia J, Bräu N, Solá R, Moreno S, Rockstroh J, Smaill F, Mendes-Correa MC, DePamphilis J, Torriani FJ; APRICOT Investigators.

J Med Virol. 2007 Jun;79(6):694-700.

PMID:
17457912
47.

Antibiotics for asymptomatic bacteriuria in pregnancy.

Smaill F, Vazquez JC.

Cochrane Database Syst Rev. 2007 Apr 18;(2):CD000490. Review. Update in: Cochrane Database Syst Rev. 2015;8:CD000490.

PMID:
17443502
48.

Asymptomatic bacteriuria in pregnancy.

Smaill F.

Best Pract Res Clin Obstet Gynaecol. 2007 Jun;21(3):439-50. Epub 2007 Mar 7. Review.

PMID:
17347050
49.

Assay of HIV gp41 amino acid sequence to identify baseline variation and mutation development in patients with virologic failure on enfuvirtide.

Loutfy MR, Raboud JM, Montaner JS, Antoniou T, Wynhoven B, Smaill F, Rouleau D, Gill J, Schlech W, Brumme ZL, Mo T, Gough K, Rachlis A, Harrigan PR, Walmsley SL.

Antiviral Res. 2007 Jul;75(1):58-63. Epub 2006 Dec 18.

PMID:
17196268
50.

Supplemental Content

Loading ...
Support Center